New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Catalyst Pharmaceutical Partners, Inc (NASDAQ:CPRX), On Track Innovations Ltd.(USA) (NASDAQ:OTIV), ARMOUR Residential REIT, Inc (NYSE:ARR), Synovus Financial Corp (NYSE:SN)
Catalyst Pharmaceutical Partners, Inc (NASDAQ:CPRX) showed a volume of 1.17 million shares by the end of last trade whereas the average volume of the stock remained 1.11 million shares. The stock opened the session at $1.90 but then moved to $1.94. At that price, the stock showed a positive performance of 1.94%. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy. As of December 31, 2011, the Company had two drugs in development: CPP-109 and CPP-115. of December 31, 2011, it was evaluating its drug candidate, CPP-109 for the treatment of cocaine addiction.
Will CPRX Continue To Move Higher? Find Out Here
On Track Innovations Ltd.(USA) (NASDAQ:OTIV) opened the session at $3.60 and closed the session at $3.69. The stock showed a positive performance of 6.03% in previous trading session. Traded with volume of 1.05 million shares in the prior session and the average volume of the stock remained 1.05 million shares. On Track Innovations Ltd. (OTI) designs, develops and markets solutions based on its secure contactless microprocessor-based smart card technology to address the needs of a range of markets. The Company’s products combine the benefits of both microprocessors and contactless cards. In addition to contactless microprocessor-based smart cards, it also sells products that are based on other card technologies.
For How Long OTIV will fight for Profitability? Read This Trend Analysis report
ARMOUR Residential REIT, Inc (NYSE:ARR) opened the session at $3.83 and closed the session at $3.89. The stock showed a positive performance of 4.01% in previous trading session. Traded with volume of 11.27 million shares in the prior session and the average volume of the stock remained 5.44 million shares. The beta of the stock remained 0.66. ARMOUR Residential REIT, Inc.( ARMOUR) is an externally-managed Maryland corporation managed by ARMOUR Residential REIT, Inc. The Company invests primarily in hybrid adjustable rate, adjustable rate and fixed rate residential mortgage backed securities (RMBS). These securities are issued or guaranteed by a United States Government-sponsored entity (GSE), such as the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac),
Why Should Investors Buy ARR After The Recent Gain? Just Go Here and Find Out
Synovus Financial Corp (NYSE:SN) the stock decreased -0.85% and finished the session at $3.49. Traded with volume of 6.86 million shares in the prior session and the average volume of the stock remained 6.14 million shares. The beta of the stock remained 1.99. Synovus Financial Corp. ( Synovus) is a financial services and a bank holding company. The Company provides integrated financial services, including commercial and retail banking, financial management, insurance and mortgage services to its customers through 29 locally-branded banking divisions of its wholly-owned subsidiary bank, Synovus Bank, and other offices in Georgia, Alabama, South Carolina,
Will SN Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)